海森药业(001367.SZ)部分董事、高级管理人员拟减持合计不超12.43万股

Group 1 - The company, Haishen Pharmaceutical (001367.SZ), announced that some directors and senior management plan to reduce their holdings of company shares by a total of 124,300 shares, which represents 0.0816% of the company's total share capital [1]